Role of 99mTechnetium Sestamibi SPECT/CT in patients with negative planar scintigraphy in lesion localization in patients with hyperparathyroidism

被引:0
|
作者
Dharmashaktu, Y. [1 ]
Damle, N. A. [1 ]
Goel, R. [1 ]
Bal, C. [1 ]
Kumar, P. [1 ]
Chumber, S. [1 ]
Puri, G. [1 ]
Aphale, R. [1 ]
机构
[1] All India Inst Med Sci, Delhi, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0505
引用
收藏
页码:S630 / S630
页数:1
相关论文
共 50 条
  • [41] Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study
    Lumachi, F
    Tregnaghi, A
    Zucchetta, P
    Marzola, MC
    Cecchin, D
    Marchesi, P
    Fallo, F
    Bui, F
    BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (914): : 100 - 103
  • [42] Usefulness of SPECT/CT in Parathyroid Lesion Detection in Patients with Thyroid Parenchymal 99mTc-Sestamibi Retention
    Hwang S.H.
    Rhee Y.
    Yun M.
    Yoon J.H.
    Lee J.W.
    Cho A.
    Nuclear Medicine and Molecular Imaging, 2017, 51 (1) : 32 - 39
  • [43] Detecting parathyroid pathologies in patients with primary hyperparathyroidism: 99mTc MIBI Parathyroid scintigraphy, SPECT and SPECT/CT.
    Mulazimoglu, M.
    Tamam, M. O.
    Ozpacaci, T.
    Koca, S.
    Uyanik, E.
    Yildiz, K.
    Ozcevik, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S284 - S284
  • [44] The value of quantitative 99mtechnetium dimercaptosuccinic acid renal scintigraphy for predicting postoperative renal insufficiency in patients undergoing nephrectomy
    Mullerad, M
    Kastin, A
    Issaq, E
    Moskovitz, B
    Groshar, D
    Nativ, O
    JOURNAL OF UROLOGY, 2003, 169 (01): : 24 - 27
  • [45] Added Value of SPECT-CT Scintigraphy in The assessment of Patients With Hyperparathyroidism
    Slim, I.
    El Bez, I.
    Meddeb, I.
    Ben Ghachem, T.
    Trabelsi, K.
    Mhiri, A.
    Yeddes, I.
    Ben Slimene, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S825 - S826
  • [46] Radiation exposure of patients with primary hyperparathyroidism with SPECT/CT and subtraction scintigraphy
    Rep, S.
    Sustar, S.
    Simonic, B.
    Hocevar, M.
    Lezaic, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S641 - S642
  • [47] Improvement of parathyroid lesion visualization in primary hyperparathyroidism with 99mTc-MIBI pinhole SPECT:: comparison with conventional SPECT and planar scintigraphy
    Ansquer, C.
    Mirallie, E.
    Oudoux, A.
    Bodet-Milin, C.
    Defrise, M.
    Seret, A.
    Daumy, I.
    Aubron, F.
    Kraeber-Bodere, F.
    Carlier, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S100 - S100
  • [48] Value of dual-phase 99mTc Sestamibi SPECT/CT in preoperative assessment of patients with primary hyperparathyroidism
    Solar, N.
    Taborska, K.
    Astl, J.
    Libansky, P.
    Smutny, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S360 - S360
  • [49] Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-Sestamibi parathyroid scintigraphy
    Lavely, William C.
    Goetze, Sibyll
    Friedman, Kent P.
    Leal, Jeffrey P.
    Zhang, Zhe
    Garret-Mayer, Elizabeth
    Dackiw, Alan P.
    Tufano, Ralph P.
    Zeiger, Martha A.
    Ziessman, Harvey A.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (07) : 1084 - 1089
  • [50] Comparison of 99mTc-sestamibi/123I subtraction SPECT/CT and combined planar pinhole image with 99mTc-sestamibi/123I subtraction SPECT/CT in hyperparathyroidism
    Seppanen, Marko
    Tunninen, Virpi
    Varjo, Pekka
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)